CClinicalTrials.gg
RecruitingNCT06657989Updated Sep 29, 2026

Optimal Intensity of Reactive Balance Training for Healthy Older Adults

An interventional study of Reactive balance training and Walking in Accidental Falls, sponsored by Toronto Rehabilitation Institute. Recruiting at 1 site in Canada. Open to participants aged 65 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-29.

Sponsored by Toronto Rehabilitation Institute · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
65 Years to 80 Years
Sex
All
01

Study summary

Falls in daily life are a serious risk for older adults. A new type of balance training, called reactive balance training (RBT) involves people losing balance many times so that they can practice fast balance reactions, like stepping reactions. Differences in training program features might explain differences in the results of previous RBT studies. Training intensity is the difficulty or challenge of the training program. It would be valuable to know if high-intensity RBT improves balance reactions quickly. The main goal of this study is to see if more intense RBT improves balance reactions faster than less intense RBT. The investigators will compare how quickly people improve balance reactions between high- and moderate-intensity RBT, and between RBT and a control program that does not include RBT. The investigators will also test if the improvements in balance reactions last after the training program is over. The secondary goals are to understand exactly how balance reactions improve with training, and to determine if people who complete RBT improve their general balance skills, and falls efficacy more than people who do not complete RBT.

02

Conditions studied

  • Accidental Falls

Keywords

  • Postural balance
  • Aging
  • Biomechanics
  • Rehabilitation
03

In context

Lead sponsor

Toronto Rehabilitation Institute is the lead sponsor of 39 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Community-dwelling older adults (65-80 years old)

Exclusion criteria

Exclusion Criteria:

  • Unable to stand independently without upper-limb support for >30 seconds and/or walk independently (without a gait aid) for ≥10 metres;
  • Diagnosed neurological condition that could affect balance control (e.g., stroke, Parkinson's disease);
  • Score below normative values on the Montreal Cognitive Assessment;
  • Score below age-matched normative values for sensory and motor function, as assessed using the FallScreen battery;
  • Have insufficient English language comprehension such that they cannot understand instructions;
  • Have contraindications to reactive balance training such as severe osteoporosis; and/or
  • Are currently attending physiotherapy or supervised exercise.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
96 participants (estimated)

Study arms

  • Experimental
    High intensity reactive balance training

    Participants will complete 5 1-hour training sessions over 11 days. During each training session, participants will complete 36 multi-directional (left-, right-, and forward-fall) perturbations. Participants assigned to high-intensity RBT will experience perturbations at 150% of the multi-step threshold; for example, for a multi-step threshold of 2 m/s\^2 the high intensity perturbation will be 3 m/s\^2.

    Behavioral: Reactive balance training

  • Active comparator
    Moderate intensity reactive balance training

    Participants will complete 5 1-hour training sessions over 11 days. During each training session, participants will complete 36 multi-directional (left-, right-, and forward-fall) perturbations. Participants assigned to moderate-intensity RBT will experience perturbations at 100% of the multi-step threshold; for example, for a multi-step threshold of 2 m/s\^2 the high intensity perturbation will be 2 m/s\^2.

    Behavioral: Reactive balance training

  • Sham comparator
    Walking control group

    Participants assigned to the walking control group will complete 36 trials of unperturbed walking in each training session.

    Behavioral: Walking

Interventions

  • BehavioralReactive balance training

    Reactive balance training involves clients experiencing repeated balance perturbations so that they can practice and improve control of reactions to avoid falling after a loss of balance.

    Also known as: Perturbation-based balance training

  • BehavioralWalking

    Overground walking

06

What researchers measure

Primary outcomes

  1. Number of reactive steps

    Learning rate for number of steps to recover from 'backward fall' balance perturbations

    Time frame: Two weeks

Secondary outcomes

  1. Step initiation time

    Time from perturbation onset time to foot off time

    Time frame: One week and 12 weeks post-training

  2. Step execution time

    Time from foot off to foot contact of the first step

    Time frame: One week and 12 weeks post-training

  3. Step length

    Difference in foot position from foot off to foot contact

    Time frame: One week and 12 weeks post-training

  4. Braking impulse

    Antero-posterior shear force generated over time on step contact

    Time frame: One week and 12 weeks post-training

  5. Mechanical margin of stability

    Distance between the extrapolated centre of mass (incorporating centre of mass position and velocity) and the edge of the base of support

    Time frame: One week and 12 weeks post-training

  6. Balance evaluation systems test

    Scale ranges from 0-100, with higher scores indicating better outcome

    Time frame: One week and 12 weeks post-training

  7. Falls efficacy scale - International

    Scale range: 10-100; higher values indicate worse outcome

    Time frame: One week, 12 weeks, and 12 months post-training

Other outcomes

  1. Fall incidence

    Falls in daily life

    Time frame: 12 months post-training

  2. Injurious fall incidence

    Time frame: 12-months post-training

  3. 5-level EuroQoL health status measure (EQ-5D-5L)

    Scale range for descriptive component: 5-25, higher values indicate worse outcome; Scale range for visual analogue scale: 0-100, higher values indicate better outcome

    Time frame: One week, 12 weeks, and 12 months post-training

  4. Number of participants with fear of falling

    Time frame: One week, 12 weeks, and 12 months post-training

  5. Number of participants with activity curtailment due to fear of falling

    Time frame: One week, 12 weeks, and 12 months post-training

07

Study locations

1 of 1 sites recruiting
  • University Health Network
    Toronto, Ontario M5G 2A2, Canada
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date, oversight details, site details and index terms
1 update, last Sep 29, 2026
Show all 1 update
  1. Sep 29, 2026
    Minor edits only
    + 4 other changes: verification date, oversight details, site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06657989
Lead sponsor
Toronto Rehabilitation Institute
Collaborators
Canadian Institutes of Health Research (CIHR)
Responsible party
Avril Mansfield (Senior Scientist, Toronto Rehabilitation Institute) — Principal investigator
First posted
Oct 26, 2024
Start date
Jan 21, 2025
Primary completion
Mar 1, 2027 (estimated)
Completion
Dec 31, 2027 (estimated)
Last update
Sep 29, 2026

Study contacts

Avril Mansfield, PhD
Contact
avril.mansfield@uhn.ca
416-597-3422 ext. 7831
David Jagroop
Contact
david.jagroop@uhn.ca
416-597-3422 ext. 7614
Avril Mansfield, PhD
principal investigator · University Health Network, Toronto

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion